North America Smart Biopsy Market (2019-2025)
The North America Smart Biopsy Market would witness market growth of 4.53% CAGR during the forecast period (2019-2025).
Smart biopsy assists in the diagnosis of cancer and helps to distinguish between healthy cells and tumor cells. Interventional radiologists and the diagnostic department conduct the procedure to detect diseases for healthcare institutions such as diagnostic centers, medical clinics, and hospitals. About 100 types of cancers are categorized by their different organs, such as colon and rectum malignant melanoma, and more. Different types of biopsies are used for diagnosis, such as skin, shave, incision and excision, center needle, fine needle aspiration, and vacuum-assisted biopsies.
Recent years have witnessed a visible rise in cancer cases, which will consequently fuel the demand for minimally invasive biopsy procedures that will drive the overall smart biopsy market growth. Growing demand for minimally invasive biopsy can be seen as a major factor accelerating the overall growth of the market. This is due to the fact that minimally invasive procedures result in less scarring and rapid recovery. This aspect is expected to drive the adoption of breast cancer treatment and the diagnosis of skin cancer to avoid complications from conventional procedures.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
Smart biopsy assists in the diagnosis of cancer and helps to distinguish between healthy cells and tumor cells. Interventional radiologists and the diagnostic department conduct the procedure to detect diseases for healthcare institutions such as diagnostic centers, medical clinics, and hospitals. About 100 types of cancers are categorized by their different organs, such as colon and rectum malignant melanoma, and more. Different types of biopsies are used for diagnosis, such as skin, shave, incision and excision, center needle, fine needle aspiration, and vacuum-assisted biopsies.
Recent years have witnessed a visible rise in cancer cases, which will consequently fuel the demand for minimally invasive biopsy procedures that will drive the overall smart biopsy market growth. Growing demand for minimally invasive biopsy can be seen as a major factor accelerating the overall growth of the market. This is due to the fact that minimally invasive procedures result in less scarring and rapid recovery. This aspect is expected to drive the adoption of breast cancer treatment and the diagnosis of skin cancer to avoid complications from conventional procedures.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Study
Market Segmentation:
By Application
- Breast cancer
- Skin cancer
- Liver cancer
- Prostate cancer and
- Others
- US
- Canada
- Mexico
- Rest of North America
- Danaher Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Canon, Inc. (Canon Medical Systems Corporation)
- Boston Scientific Corporation
- Olympus Corporation
- Hologic, Inc.
- B. Braun Melsungen AG
- Cook Medical, Inc. (Cook Group)
- Medtronic Plc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Smart Biopsy Market, by Application
1.4.2 North America Smart Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. MARKET ANALYSIS
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Nov – 2016-May) Leading Players
CHAPTER 4. NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION
4.1 North America Breast cancer Market by Country
4.2 North America Skin cancer Market by Country
4.3 North America Liver cancer Market by Country
4.4 North America Prostate cancer Market by Country
4.5 North America Others Market by Country
CHAPTER 5. NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY
5.1 USA Smart Biopsy Market
5.1.1 USA Smart Biopsy Market by Application
5.2 Canada Smart Biopsy Market
5.2.1 Canada Smart Biopsy Market by Application
5.3 Mexico Smart Biopsy Market
5.3.1 Mexico Smart Biopsy Market by Application
5.4 Rest of North America Smart Biopsy Market
5.4.1 Rest of North America Smart Biopsy Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Smart Biopsy Market, by Application
1.4.2 North America Smart Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. MARKET ANALYSIS
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Nov – 2016-May) Leading Players
CHAPTER 4. NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION
4.1 North America Breast cancer Market by Country
4.2 North America Skin cancer Market by Country
4.3 North America Liver cancer Market by Country
4.4 North America Prostate cancer Market by Country
4.5 North America Others Market by Country
CHAPTER 5. NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY
5.1 USA Smart Biopsy Market
5.1.1 USA Smart Biopsy Market by Application
5.2 Canada Smart Biopsy Market
5.2.1 Canada Smart Biopsy Market by Application
5.3 Mexico Smart Biopsy Market
5.3.1 Mexico Smart Biopsy Market by Application
5.4 Rest of North America Smart Biopsy Market
5.4.1 Rest of North America Smart Biopsy Market by Application
CHAPTER 6. COMPANY PROFILES
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis
LIST OF TABLES
TABLE 1 NORTH AMERICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– SMART BIOPSY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES– SMART BIOPSY DEVICES MARKET
TABLE 5 EXPANSIONS– SMART BIOPSY DEVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – SMART BIOPSY DEVICES MARKET
TABLE 7 NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA SKIN CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA SKIN CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 USA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 22 USA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 23 USA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 24 USA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 25 CANADA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 26 CANADA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 27 CANADA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 28 CANADA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 29 MEXICO SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 30 MEXICO SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 31 MEXICO SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 32 MEXICO SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 33 REST OF NORTH AMERICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 34 REST OF NORTH AMERICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 35 REST OF NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 36 REST OF NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 37 KEY INFORMATION – DANAHER CORPORATION
TABLE 38 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 39 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 40 KEY INFORMATION – CANON, INC.
TABLE 41 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 42 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 43 KEY INFORMATION – HOLOGIC, INC.
TABLE 44 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 45 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 46 KEY INFORMATION – MEDTRONIC PLC
TABLE 1 NORTH AMERICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– SMART BIOPSY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES– SMART BIOPSY DEVICES MARKET
TABLE 5 EXPANSIONS– SMART BIOPSY DEVICES MARKET
TABLE 6 MERGERS & ACQUISITIONS – SMART BIOPSY DEVICES MARKET
TABLE 7 NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA SKIN CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA SKIN CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA SMART BIOPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 USA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 22 USA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 23 USA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 24 USA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 25 CANADA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 26 CANADA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 27 CANADA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 28 CANADA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 29 MEXICO SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 30 MEXICO SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 31 MEXICO SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 32 MEXICO SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 33 REST OF NORTH AMERICA SMART BIOPSY MARKET, 2015 - 2018, USD MILLION
TABLE 34 REST OF NORTH AMERICA SMART BIOPSY MARKET, 2019 - 2025, USD MILLION
TABLE 35 REST OF NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 36 REST OF NORTH AMERICA SMART BIOPSY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 37 KEY INFORMATION – DANAHER CORPORATION
TABLE 38 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 39 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 40 KEY INFORMATION – CANON, INC.
TABLE 41 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 42 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 43 KEY INFORMATION – HOLOGIC, INC.
TABLE 44 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 45 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 46 KEY INFORMATION – MEDTRONIC PLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-NOV – 2016-MAY) LEADING PLAYERS
FIG 5 SWOT ANALYSIS: DANAHER CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: CANON, INC. (CANON MEDICAL SYSTEMS CORPORATION)
FIG 7 SWOT ANALYSIS: CANON, INC.
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 9 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: HOLOGIC, INC.
FIG 12 SWOT ANALYSIS: HOLOGIC, INC.
FIG 13 SWOT ANALYSIS: MEDTRONIC PLC
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-NOV – 2016-MAY) LEADING PLAYERS
FIG 5 SWOT ANALYSIS: DANAHER CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: CANON, INC. (CANON MEDICAL SYSTEMS CORPORATION)
FIG 7 SWOT ANALYSIS: CANON, INC.
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 9 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION
FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 11 RECENT STRATEGIES AND DEVELOPMENTS: HOLOGIC, INC.
FIG 12 SWOT ANALYSIS: HOLOGIC, INC.
FIG 13 SWOT ANALYSIS: MEDTRONIC PLC
